An Agarose Plate Method for Detecting Alloantisera to Coagulant Factor IX and Factor IX Antigen

Abstract
An agarose plate method for detecting human alloantibodies (inhibitors) to coagulant factor IX was developed. The assays was based on the ability of such antisera to inhibit coagulation of a mixture of hemophilia B plasma, normal plasma and platelet substitute in an agarose matrix. The agarose plate method was also adopted to measure levels of FIX antigen (IX:Ag) in plasma. Using this technique, 12 of 17 obligate carriers of hemophilia B demonstrated reduced levels of IX:Ag. Of the 5 carriers with normal IX:Ag levels, 3 were members of kindred in which affected individuals had normal or near normal levels of IX:Ag.